Soluble Biotech

Soluble Biotech is owned by Predictive Oncology.

Predictive Oncology is a company listed under the stock ticker POAI (US).

View the org chart displaying its 4 main executives

Most searched biographies at Soluble Biotech

• Larry Delucas, Chief Executive Officer
• Keith Champion, Director of Operations
• Chrysanty Weaver, Director of Research

Create your alert
to follow the executive moves at Soluble Biotech.

Predictive Oncology has 2,297 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Johnson & Johnson has announced the acquisition of Proteologix  (posted on May 20 2024).
• Rapport Therapeutics has just announced a $100 Million fundraising (posted on May 20 2024).
• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Soluble Biotech

Social media about Soluble Biotech

• Soluble Biotech on Wikipedia, Google News & Yahoo Finance
• Soluble Biotech on LinkedIn, Twitter & YouTube

Contact by email its executives including Larry Delucas

Call Soluble Biotech at +1 65...

View the org chart

Register to receive your alert

Report an error